Showing results (11-20 of 79) with videos related to
Sort By:
Pageof 8
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|June 2, 2009
Heart protection: a key target in the management of patients with diabetesJean-Jacques Mourad, Sylvain Le JeuneAmerican Journal of Hypertension|July 15, 2021
Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical TrialsBernard I Lévy, Jean Jacques MouradJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 15, 2009
Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progressJean-Jacques Mourad, Sylvain Le JeuneCurrent Hypertension Reports|September 24, 2010
Nighttime blood pressure: a target for therapy?Bernard Waeber, Jean-Jacques Mourad, Eoin O'BrienAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 4, 2016
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and AmlodipineMichel E Bertrand, Charalambos Vlachopoulos, Jean-Jacques MouradVascular Health and Risk Management|June 20, 2008
Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 studyJean-Jacques Mourad, Dulce Lameira, Pierre-Jean GuillausseauBiochimie|June 21, 2021
Coronaviruses, cholesterol and statins: Involvement and application for Covid-19Stéphane Orlowski, Jean-Jacques Mourad, Antonio Gallo, et al.Vascular Health and Risk Management|June 23, 2007
Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trialJean-Jacques Mourad, Viet Nguyen, Marilucy Lopez-Sublet, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevanceChristophe Meune, Jean-Jacques Mourad, Jean-François Bergmann, et al.Journal of Hypertension|July 26, 2019
Feasibility of 24-h central blood pressure monitoring: experience from multinational clinical trial assessing the efficacy of perindopril/indapamide/amlodipineJirar Topouchian, Jean-Jacques Mourad, Martine De Champvallins, et al.Pageof 8